SANTORO, Armando

SANTORO, Armando  

Mostra records
Risultati 1 - 20 di 962 (tempo di esecuzione: 0.04 secondi).
Titolo Data di pubblicazione Autore(i) File
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 1-gen-2006 Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A.
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 1-gen-2006 Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 1-gen-2022 Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R.
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 1-gen-2021 Navarria, Pierina; Pessina, Federico; Franzese, Ciro; Loi, Mauro; Bellu, Luisa; Clerici, Elena; Marco Marzo, Antonio; Simonelli, Matteo; Lorenzi, Elena; Salvatore Politi, Letterio; Bello, Lorenzo; Fornari, Maurizio; Rossini, Zefferino; Santoro, Armando; Scorsetti, Marta
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients 1-gen-2016 Paladini, L; Bottai, G; Raschioni, C; Sagona, A; Errico, V; Torrisi, R; Canavese, G; Gatzmeier, W; Barbieri, E; Rubino, A; Rossetti, C; Eboli, M; Malerba, P; Scorsetti, M; Antunovic, L; Alloisio, M; Santoro, A; Testori, A; Tinterri, C; Santarpia, L
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 1-gen-2018 Losurdo, A; De Sanctis, R; Fernandes, B; Errico, V; Sagona, A; Masci, G; Zuradelli, M; Agostinetto, E; Torrisi, R; Gatzemeier, W; Testori, A; Roncalli, M; Alloisio, M; Tinterri, C; Santoro, A
A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies 1-gen-2003 Berardi, Ac; Parafioriti, A; Barisani, D; Papp, B; Armiraglio, E; Martinoli, M; Dalpra, L; Santoro, A
A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer 1-gen-2014 Chan, S; Campone, M; Santoro, A; Conte, P F; Bostnavaron, M; Nguyen, L
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma 1-gen-2018 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer. 1-gen-2014 Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma 1-gen-2020 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A prospective observational study to evaluate G-CSF usage inpatients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice. 1-gen-2014 Barni, S; Lorusso, V; Giordano, M; Sogno, G; Gamucci, T; Santoro, A; Passalacqua, R; Iaffaioli, V; Zilembo, N; Mencoboni, M; Roselli, M; Pappagallo, G; Pronzato, P
A prospective study on survival in cancer patients with and without venous thromboembolism 1-gen-2013 Agnelli, G; Verso, M; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino, L; Labianca, R
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma 1-gen-2001 Gortzak, E; Azzarelli, A; Buesa, J; Bramwell, Vhc; van Coevorden, F; van Geel, An; Ezzat, A; Santoro, A; Oosterhuis, Jw; van Glabbeke, M; Kirkpatrick, A; Verweij, J
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer 1-gen-2009 Ychou, M.; Hohenberger, W.; Thezenas, S.; Navarro, M.; Maurel, J.; Bokemeyer, C.; Shacham-Shmueli, E.; Rivera, F.; Choi C., Kwok-Keung; Santoro, A
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial 1-gen-2009 Infante, M.; Cavuto, S.; Lutman, F. R.; Brambilla, G.; Chiesa, G.; Ceresoli, G.; Passera, E.; Angeli, E.; Chiarenza, M.; Aranzulla, G.; Cariboni, U.; Errico, V.; Inzirillo, F.; Bottoni, E.; Voulaz, E.; Alloisio, M.; Destro, A.; Roncalli, M.; Santoro, A.; Ravasi, G.; Study Group, Dante
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study 1-gen-2015 Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 1-gen-2018 Sarina, B; Mariotti, J; Bramanti, S; Crocchiolo, R; Rimondo, A; Tordato, F; Pocaterra, D; Casari, E; De Philippis, C; Carlo-Stella, C; Santoro, A; Castagna, L
A SUMMARY OF THE MILAN EXPERIENCE WITH MULTIMODALITY THERAPIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - ATTEMPTS TO IMPROVE LONG-TERM OUTCOME 1-gen-1995 Santoro, A; Parra, Hs; Bidoli, P; Angelidou, M; Cataldo, I; Salvini, P; Valagussa, P; Milani, F; Ravasi, G; Benadonna, G
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival 1-gen-2006 Masci, G; Di Tommaso, L; Del Prato, I; Orefice, S; Rubino, A; Morenghi, E; Salvini, P; Alloisio, M; Morenghi, E; Roncalli, M; Santoro, A